Literature DB >> 4028523

Renal prognosis in women with hereditary nephritis.

J P Grünfeld, L H Noël, S Hafez, D Droz.   

Abstract

Renal prognosis cannot be easily predicted in females with hereditary nephritis (HN). Thirty-six women with persistent urinary abnormalities, belonging to 24 families with progressive HN, were studied. Renal biopsy specimens were available in 23 patients and were studied by light and electron microscopy (EM). Nine women (group I) progressed to early renal failure, at 35 yrs of age or less. Five women (group II) progressed to late renal failure at 45 yrs of age or more. In contrast, 22 patients have so far normal renal function, and 14 of these (group IV) range from 31 to 62 yrs of age. Diffuse glomerular basement membrane (GBM) thickening was found by EM in 6 of 7 cases of group I, whereas it was found in no patient of group IV. The following features are suggestive of progressive nephritis in females: gross hematuria in childhood, nephrotic syndrome, and diffuse GBM thickening by EM. In contrast, family history of HN without nerve deafness, normal or nearly normal kidney on repeat biopsy, and thin or normal GBM by EM are suggestive of less or nonprogressive renal disease. Further follow-up is needed to assess the prognostic significance of these features.

Entities:  

Mesh:

Year:  1985        PMID: 4028523

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  16 in total

1.  Should women who are known or potential carriers of the Alport gene be accepted as kidney donors?

Authors:  C E Kashtan
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

Review 2.  Familial hematurias: what we know and what we don't.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

3.  Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele.

Authors:  C Guo; B Van Damme; Y Vanrenterghem; K Devriendt; J J Cassiman; P Marynen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Samoyed hereditary glomerulopathy (SHG). Evolution of splitting of glomerular capillary basement membranes.

Authors:  B Jansen; P Thorner; R Baumal; V Valli; M G Maxie; A Singh
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

5.  Renal disease in carrier female dogs with X-linked hereditary nephritis. Implications for female patients with this disease.

Authors:  R Baumal; P Thorner; V E Valli; R McInnes; P Marrano; R Jacobs; A Binnington; A G Bloedow
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

6.  Samoyed hereditary glomerulopathy: serial, clinical and laboratory (urine, serum biochemistry and hematology) studies.

Authors:  B Jansen; V E Valli; P Thorner; R Baumal; J H Lumsden
Journal:  Can J Vet Res       Date:  1987-07       Impact factor: 1.310

7.  X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome.

Authors:  Michelle N Rheault; Stefan M Kren; Linda A Hartich; Melanie Wall; William Thomas; Hector A Mesa; Philip Avner; George E Lees; Clifford E Kashtan; Yoav Segal
Journal:  Nephrol Dial Transplant       Date:  2009-10-23       Impact factor: 5.992

8.  Alport Syndrome in Women and Girls.

Authors:  Judy Savige; Deb Colville; Michelle Rheault; Susie Gear; Rachel Lennon; Sharon Lagas; Moira Finlay; Frances Flinter
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-10       Impact factor: 8.237

9.  Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative.

Authors:  Clifford E Kashtan; Jie Ding; Martin Gregory; Oliver Gross; Laurence Heidet; Bertrand Knebelmann; Michelle Rheault; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2012-03-30       Impact factor: 3.714

10.  Alport's Syndrome in Pregnancy.

Authors:  Suchita Mehta; Chadi Saifan; Marie Abdellah; Rita Choueiry; Rabih Nasr; Suzanne El-Sayegh
Journal:  Case Rep Med       Date:  2013-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.